The Need for and Challenges of Nutrition and Dietetics Registry Studies: An Update on the Academy of Nutrition and Dietetics Health Informatics Infrastructure.

Autor: Colin CR; Department of Nutrition and Dietetics, Brooks College of Health, University of North Florida, Jacksonville, Florida., Woodcock L; Academy of Nutrition and Dietetics, Chicago, Illinois., Wright LY; Department of Nutrition and Dietetics, Brooks College of Health, University of North Florida, Jacksonville, Florida., Yakes Jimenez E; Academy of Nutrition and Dietetics, Chicago, Illinois; Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico; College of Population Health, University of New Mexico, Albuquerque, New Mexico., Papoutsakis C; Academy of Nutrition and Dietetics, Chicago, Illinois. Electronic address: cpapoutsakis@eatright.org.

Publikováno v: Journal of the Academy of Nutrition and Dietetics [J Acad Nutr Diet] 2023 Apr; Vol. 123 (4), pp. 673-682. Date of Electronic Publication: 2023 Jan 06.

A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.

Autor: Young G; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA., Liesner R; Great Ormond Street Hospital, London, United Kingdom., Chang T; Genentech, Inc, South San Francisco, CA., Sidonio R; Children's Healthcare of Atlanta, Emory University, Atlanta, GA., Oldenburg J; Institute of Experimental Hematology and Transfusion Medicine, University of Bonn, Bonn, Germany., Jiménez-Yuste V; Hospital Universitario La Paz, Autónoma University, Madrid, Spain., Mahlangu J; National Health Laboratory Service (NHLS), Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Kruse-Jarres R; Bloodworks Northwest, Seattle, WA., Wang M; School of Medicine Hemophilia and Thrombosis Center, Anschutz Medical Campus, University of Colorado, Aurora, CO., Uguen M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Doral MY; Genentech, Inc, South San Francisco, CA., Wright LY; Genentech, Inc, South San Francisco, CA., Schmitt C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Levy GG; Genentech, Inc, South San Francisco, CA., Shima M; Department of Pediatrics, Nara Medical University, Kashihara, Japan; and., Mancuso ME; Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Ospedale Maggiore Policlinico, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda, Milan, Italy.

Publikováno v: Blood [Blood] 2019 Dec 12; Vol. 134 (24), pp. 2127-2138.

Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.

Autor: Kauder SE; Discovery Immunology, Genentech Inc., South San Francisco, California, United States of America., Santell L; Early Discovery Biochemistry, Genentech Inc., South San Francisco, California, United States of America., Mai E; Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, California, United States of America., Wright LY; Immunology, Tissue Growth and Repair- Diagnostics Discovery, Genentech Inc., South San Francisco, California, United States of America., Luis E; Protein Chemistry, Genentech Inc., South San Francisco, California, United States of America., N'Diaye EN; Discovery Immunology, Genentech Inc., South San Francisco, California, United States of America., Lutman J; Pharmacokinetics and Pharmacodynamics, Genentech Inc., South San Francisco, California, United States of America., Ratti N; Pathology, Genentech Inc., South San Francisco, California, United States of America., Sa SM; Pathology, Genentech Inc., South San Francisco, California, United States of America., Maun HR; Early Discovery Biochemistry, Genentech Inc., South San Francisco, California, United States of America., Stefanich E; Pharmacokinetics and Pharmacodynamics, Genentech Inc., South San Francisco, California, United States of America., Gonzalez LC; Protein Chemistry, Genentech Inc., South San Francisco, California, United States of America., Graham RR; Immunology, Tissue Growth and Repair -Human Genetics, Genentech Inc., South San Francisco, California, United States of America., Diehl L; Pathology, Genentech Inc., South San Francisco, California, United States of America., Faubion WA Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America., Keir ME; Immunology, Tissue Growth and Repair- Diagnostics Discovery, Genentech Inc., South San Francisco, California, United States of America., Young J; Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, California, United States of America., Chaudhuri A; Molecular Oncology, Genentech Inc., South San Francisco, California, United States of America., Lazarus RA; Early Discovery Biochemistry, Genentech Inc., South San Francisco, California, United States of America., Egen JG; Discovery Immunology, Genentech Inc., South San Francisco, California, United States of America.

Publikováno v: PloS one [PLoS One] 2013 Dec 23; Vol. 8 (12), pp. e83958. Date of Electronic Publication: 2013 Dec 23 (Print Publication: 2013).

Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent.

Autor: Ikawa T; Division of Biological Sciences, 0377 University of California, San Diego, La Jolla, CA 92093, USA., Kawamoto H, Wright LY, Murre C

Publikováno v: Immunity [Immunity] 2004 Mar; Vol. 20 (3), pp. 349-60.

The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study.

Autor: Fletcher, Simon¹ (AUTHOR) sfletcher26@aol.com, Jenner, Kathryn² (AUTHOR), Pembroke, Luke² (AUTHOR), Holland, Michael² (AUTHOR), Khair, Kate² (AUTHOR)

Publikováno v: Orphanet Journal of Rare Diseases. 4/4/2022, Vol. 17 Issue 1, p1-9. 9p.